文献速递神经肿瘤

HLA多态性对成人胶质瘤风险的非加性与上位性效应

Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.
PubMed 文献 · J Neurooncol · 2017-07-18

基于GliomaScan联盟1746例成人胶质瘤患者和2312例欧洲裔对照,对HLA区域变异进行综合分析,采用Illumina 660-Quad芯片基因分型并推算HLA等位基因。研究发现HLA-DRB1*1501-DQA1*0102-DQB1*0602多基因单倍型在非加性模型下与胶质瘤风险相关,杂合携带者风险升高(OR 1.23;95%CI 1.01-1.49),纯合携带者风险降低(OR 0.64;95%CI 0.40-1.01),其正显性效应部分由与HLA-DRB1*0401-DQA1*0301-DQB1*0301的上位性交互解释。

要点

  • HLA-DRB1*1501-DQA1*0102-DQB1*0602杂合携带者胶质瘤风险升高(OR 1.23;95%CI 1.01-1.49)。
  • 该单倍型纯合携带者较非携带者风险降低(OR 0.64;95%CI 0.40-1.01)。
  • 该单倍型的正显性效应部分由与HLA-DRB1*0401-DQA1*0301-DQB1*0301的上位性交互解释。

核心结论

  • HLA-DRB1*1501-DQA1*0102-DQB1*0602单倍型可能以非加性方式贡献成人胶质瘤风险,其正显性效应部分由与HLA-DRB1*0401-DQA1*0301-DQB1*0301的上位性交互解释。

研究设计与样本

  • 研究纳入GliomaScan联盟1746例成人胶质瘤患者和2312例欧洲裔对照,采用Illumina 660-Quad芯片进行基因分型。
  • HLA等位基因推算使用1型糖尿病遗传学联盟5225例经下一代测序高分辨率HLA分型个体的参考面板。
  • 病例对照比较使用祖先信息主成分校正人群分层,并构建由DRB1、DQA1和DQB1基因组成的多基因单倍型进行分析。

主要发现

  • 在加性模型中,未发现任何单倍型与胶质瘤相关。
  • 纳入显性项后,多基因单倍型HLA-DRB1*1501-DQA1*0102-DQB1*0602的模型显著改善(P = 0.002)。
  • 该单倍型杂合携带者较非携带者胶质瘤风险升高(OR 1.23;95%CI 1.01-1.49)。
  • 该单倍型纯合携带者较非携带者胶质瘤风险降低(OR 0.64;95%CI 0.40-1.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although genome-wide association studies have identified several susceptibility loci for adult glioma, little is known regarding the potential contribution of genetic variation in the human leukocyte antigen (HLA) region to glioma risk. HLA associations have been reported for various malignancies, with many studies investigating selected candidate HLA polymorphisms. However, no systematic analysis has been conducted in glioma patients, and no investigation into potential non-additive effects has been described. We conducted comprehensive genetic analyses of HLA variants among 1746 adult glioma patients and 2312 controls of European-ancestry from the GliomaScan Consortium. Genotype data were generated with the Illumina 660-Quad array, and we imputed HLA alleles using a reference panel of 5225 individuals in the Type 1 Diabetes Genetics Consortium who underwent high-resolution HLA typing via next-generation sequencing. Case-control comparisons were adjusted for population stratification using ancestry-informative principal components. Because alleles in different loci across the HLA region are linked, we created multigene haplotypes consisting of the genes DRB1, DQA1, and DQB1. Although none of the haplotypes were associated with glioma in additive models, inclusion of a dominance term significantly improved the model for multigene haplotype HLA-DRB1*1501-DQA1*0102-DQB1*0602 (P = 0.002). Heterozygous carriers of the haplotype had an increased risk of glioma [odds ratio (OR) 1.23; 95% confidence interval (CI) 1.01-1.49], while homozygous carriers were at decreased risk compared with non-carriers (OR 0.64; 95% CI 0.40-1.01). Our results suggest that the DRB1*1501-DQA1*0102-DQB1*0602 haplotype may contribute to the risk of glioma in a non-additive manner, with the positive dominance effect partly explained by an epistatic interaction with HLA-DRB1*0401-DQA1*0301-DQB1*0301.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zhang C, de Smith AJ, Smirnov IV, et al. Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma. J Neurooncol. 2017. PMID: 28721485. doi:10.1007/s11060-017-2569-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。